TFC Financial Management’s Apellis Pharmaceuticals APLS Stock Holding History

TFC Financial Management’s Portfolio APLS Stock Details APLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-212	Closed	-$8.53K	–	1039
2026 Q1	$8.53K	Hold	212	–	–	﹤0.01%	410
2025 Q4	$5.33K	Buy	+212	New	+$4.97K	﹤0.01%	440
2025 Q3	–	Sell	-23	Closed	-$399	–	1002
2025 Q2	$399	Buy	+23	New	+$426	﹤0.01%	722
2024 Q3	–	Sell	-128	Closed	-$4.91K	–	1012
2024 Q2	$4.91K	Buy	128 +92	+256%	+$4.17K	﹤0.01%	392
2024 Q1	$2.12K	Buy	+36	New	+$2.29K	﹤0.01%	461

Other funds holding APLS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

TFC Financial Management's APLS Position: Q2 2026 in Review

TFC Financial Management sold out of Apellis Pharmaceuticals (APLS) in Q2 2026, closing a stake of 212 shares — an estimated $8.53K sold.

TFC Financial Management first reported a position in APLS in Q1 2024 and held it in 5 quarters. The position peaked at $8.53K in Q1 2026. 1 fund tracked by Wall St. Rank holds APLS as of Q2 2026.

TFC Financial Management reported no remaining Apellis Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
TFC Financial Management sold 212 Apellis Pharmaceuticals shares in Q2 2026, an estimated $8.53K.
TFC Financial Management first reported a position in Apellis Pharmaceuticals in Q1 2024 and held it in 5 quarters.
TFC Financial Management's Apellis Pharmaceuticals position peaked at $8.53K in Q1 2026.
1 fund tracked by Wall St. Rank held Apellis Pharmaceuticals as of Q2 2026.

Based on TFC Financial Management's 13F filing for Q2 2026, filed 23 Jul 2026.